# Hemovent expands manufacturing facility for ECLS device serial production

Hemovent GmbH has completed the expansion of its manufacturing facility to accommodate serial production of its ECLS device. The company is on schedule to achieve its first-in-man milestone in the second half of 2018.

- Type: Expansion
- Announced: 2017-10-16
- Where: Aachen, Germany
- Starts operating: Q3 2018
- Status: completed
- Products: ExtraCorporeal Life Support (ECLS) device, artificial lung platform
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Hemovent GmbH](https://endata.com/companies/27901.md)

## Sources

- [biospace.com](https://www.biospace.com/hemovent-successfully-debuts-extracorporeal-life-support-ecls-device-from-its-artificial-lung-platform), 2017-10-16: "We have completed the expansion of our manufacturing facility in order to accommodate serial production of our device and are well on schedule to achieve our first-in-man milestone in the second half of 2018."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.